PDGFRB and neoplasm: As a single gene, the expression of PDGFRB performed remarkably well in predicting CMS4 status in the original composite cohort of 3232 primary tumours [21] (AUROC = 0.86; 95% CI: 0.85−0.88) (Figure 1C).